Detail akcie Intuitive Surgical online

Business Summary: Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Intuitive Surgical Inc revenues increased 19% to $2.25B. Net income increased 28% to $698.4M. Revenues reflect Instruments and accessories segment increase of 18% to $1.37B, Systems segment increase of 25% to $522.7M, U.S. segment increase of 24% to $1.54B, Outside of United states segment increase of 10% to $715.2M. Net income benefited from Interest and other income.